Search Results Search Sort by RelevanceMost Recent Case and Commentary Oct 2019 How Should Decision Science Inform Scarce Blood Product Allocation? Eric Kersjes, MD and Lauren B. Smith, MD Decision aids could help clinicians know when to request ethics consultation or re-evaluate blood product usage in a specific patient care situation. AMA J Ethics. 2019;21(10):E852-857. doi: 10.1001/amajethics.2019.852. Medicine and Society Oct 2019 How Should Decision Aids Be Used During Counseling to Help Patients Who Are “Genetically at Risk”? Natalie Evans, PhD, Suzanne Metselaar, PhD, Carla van El, PhD, Nina Hallowell, DPhil, MA, and Guy Widdershoven, PhD Prognostic uncertainty about risk creates demand for ongoing communication and facilitated reflection about goals and values. AMA J Ethics. 2019;21(10):E865-872. doi: 10.1001/amajethics.2019.865. Letter to the Editor Oct 2019 Response to “Emerging Roles of Virtual Patients in the Age of AI” Frederick W. Kron, MD, Timothy C. Guetterman, PhD, and Michael D. Fetters, MD, MPH, MA Selected ideas in C. Donald Combs and P. Ford Combs’ article, “Emerging Roles of Virtual Patients in the Age of AI,” are further considered. AMA J Ethics. 2019;21(10):E920-925. doi: 10.1001/amajethics.2019.920. Viewpoint Oct 2019 How Moral Case Deliberation Supports Good Clinical Decision Making Giulia Inguaggiato, MPhil, Suzanne Metselaar, PhD, Bert Molewijk, PhD, and Guy Widdershoven, PhD Clarifying both patients’ and professionals’ values fosters good clinical decision making, particularly in situations of uncertainty. AMA J Ethics. 2019;21(10):E913-919. doi: 10.1001/amajethics.2019.913. Case and Commentary Nov 2019 Should a Caregiver’s QoL Be Considered in Decisions About Whether a Patient Has an Experimental Double-Hand Transplant? Miguel I. Dorante, MD, MBE, Elaine Devine, MSW, LICSW, and Simon G. Talbot, MD Success depends on strong support, rehabilitation, adherence, and social integration. AMA J Ethics. 2019;21(11):E943-952. doi: 10.1001/amajethics.2019.943. Medicine and Society Nov 2019 What Are Good Guidelines for Evaluating Uterus Transplantation? Margaret Horvat, MA and Ana Iltis, PhD Recent advances in UTx suggest it is on a trajectory toward becoming an accepted clinical practice to treat absolute uterine factor infertility. AMA J Ethics. 2019;21(11):E988-995. doi: 10.1001/amajethics.2019.988. Medicine and Society Nov 2019 What Hand Transplantation Teaches Us About Embodiment Brock Bahler, PhD Current QoL conversations in HTx could be enhanced by a phenomenological account of temporality, embodiment, and intersubjectivity. AMA J Ethics. 2019;21(11):E996-1002. doi: 10.1001/amajethics.2019.996. Case and Commentary Dec 2019 Using the 4-S Framework to Guide Conversations With Patients About CRISPR Lisa S. Lehmann, MD, PhD, MSc Empathic communication skills help motivate understanding of safety, significance of harms, impact on succeeding generations, and social consequences. AMA J Ethics. 2019;21(12):E1029-1035. doi: 10.1001/amajethics.2019.1029. Case and Commentary Dec 2019 How Should “CRISPRed” Babies Be Monitored Over Their Life Course to Promote Health Equity? Charis Thompson, PhD Transnational monitoring efforts should focus on safety, defining standard of care, and promoting just access to innovation. AMA J Ethics. 2019;21(12):E1036-1041. doi: 10.1001/amajethics.2019.1036. State of the Art and Science Jun 2017 Initiatives for Responding to Medical Trainees’ Moral Distress about End-of-Life Cases M. Sara Rosenthal, PhD and Maria Clay, PhD Medical students’ moral distress about end-of-life cases can be reduced through ethics consultation and ethics rounds, narrative reflection, and mentoring. AMA J Ethics. 2017;19(6):585-594. doi: 10.1001/journalofethics.2017.19.6.stas1-1706. Pagination First page « First Previous page ‹ Previous … Page 4 Page 5 Page 6 Page 7 Current page 8 Page 9 Page 10 Page 11 Page 12 … Next page Next › Last page Last »
Case and Commentary Oct 2019 How Should Decision Science Inform Scarce Blood Product Allocation? Eric Kersjes, MD and Lauren B. Smith, MD Decision aids could help clinicians know when to request ethics consultation or re-evaluate blood product usage in a specific patient care situation. AMA J Ethics. 2019;21(10):E852-857. doi: 10.1001/amajethics.2019.852.
Medicine and Society Oct 2019 How Should Decision Aids Be Used During Counseling to Help Patients Who Are “Genetically at Risk”? Natalie Evans, PhD, Suzanne Metselaar, PhD, Carla van El, PhD, Nina Hallowell, DPhil, MA, and Guy Widdershoven, PhD Prognostic uncertainty about risk creates demand for ongoing communication and facilitated reflection about goals and values. AMA J Ethics. 2019;21(10):E865-872. doi: 10.1001/amajethics.2019.865.
Letter to the Editor Oct 2019 Response to “Emerging Roles of Virtual Patients in the Age of AI” Frederick W. Kron, MD, Timothy C. Guetterman, PhD, and Michael D. Fetters, MD, MPH, MA Selected ideas in C. Donald Combs and P. Ford Combs’ article, “Emerging Roles of Virtual Patients in the Age of AI,” are further considered. AMA J Ethics. 2019;21(10):E920-925. doi: 10.1001/amajethics.2019.920.
Viewpoint Oct 2019 How Moral Case Deliberation Supports Good Clinical Decision Making Giulia Inguaggiato, MPhil, Suzanne Metselaar, PhD, Bert Molewijk, PhD, and Guy Widdershoven, PhD Clarifying both patients’ and professionals’ values fosters good clinical decision making, particularly in situations of uncertainty. AMA J Ethics. 2019;21(10):E913-919. doi: 10.1001/amajethics.2019.913.
Case and Commentary Nov 2019 Should a Caregiver’s QoL Be Considered in Decisions About Whether a Patient Has an Experimental Double-Hand Transplant? Miguel I. Dorante, MD, MBE, Elaine Devine, MSW, LICSW, and Simon G. Talbot, MD Success depends on strong support, rehabilitation, adherence, and social integration. AMA J Ethics. 2019;21(11):E943-952. doi: 10.1001/amajethics.2019.943.
Medicine and Society Nov 2019 What Are Good Guidelines for Evaluating Uterus Transplantation? Margaret Horvat, MA and Ana Iltis, PhD Recent advances in UTx suggest it is on a trajectory toward becoming an accepted clinical practice to treat absolute uterine factor infertility. AMA J Ethics. 2019;21(11):E988-995. doi: 10.1001/amajethics.2019.988.
Medicine and Society Nov 2019 What Hand Transplantation Teaches Us About Embodiment Brock Bahler, PhD Current QoL conversations in HTx could be enhanced by a phenomenological account of temporality, embodiment, and intersubjectivity. AMA J Ethics. 2019;21(11):E996-1002. doi: 10.1001/amajethics.2019.996.
Case and Commentary Dec 2019 Using the 4-S Framework to Guide Conversations With Patients About CRISPR Lisa S. Lehmann, MD, PhD, MSc Empathic communication skills help motivate understanding of safety, significance of harms, impact on succeeding generations, and social consequences. AMA J Ethics. 2019;21(12):E1029-1035. doi: 10.1001/amajethics.2019.1029.
Case and Commentary Dec 2019 How Should “CRISPRed” Babies Be Monitored Over Their Life Course to Promote Health Equity? Charis Thompson, PhD Transnational monitoring efforts should focus on safety, defining standard of care, and promoting just access to innovation. AMA J Ethics. 2019;21(12):E1036-1041. doi: 10.1001/amajethics.2019.1036.
State of the Art and Science Jun 2017 Initiatives for Responding to Medical Trainees’ Moral Distress about End-of-Life Cases M. Sara Rosenthal, PhD and Maria Clay, PhD Medical students’ moral distress about end-of-life cases can be reduced through ethics consultation and ethics rounds, narrative reflection, and mentoring. AMA J Ethics. 2017;19(6):585-594. doi: 10.1001/journalofethics.2017.19.6.stas1-1706.